Literature DB >> 30341517

Robotic-assisted Laparoscopic Nephrectomy with Vein Thrombectomy: Initial Experience and Outcomes from a Single Surgeon.

Xin-Wen Ke1,2, Xing Zeng1, Xian Wei1, Yuan-Qing Shen1, Jia-Hua Gan1, Ji-Hua Tian1, Zhi-Quan Hu3.   

Abstract

This study was designed to explore the safety and feasibility of robotic-assisted laparoscopic nephrectomy with vein thrombectomy (RAL-NVT) for the treatment of renal cell carcinoma (RCC) with venous tumor thrombus (VTT). Clinical data of 6 patients treated with RAL-NVT between July 2016 and November 2017 in our hospital were retrospectively collected and analyzed. There were 5 males and 1 female with their age ranging from 48 years to 68 years. Five renal tumors were right-sided and one left-sided. Three cases fell in level 0 VTT, one in level I and two in level II. Preoperative imaging revealed lymph node involvement in 1 case and distant metastasis in 2 cases. For RCC with level 0 VTT, the renal vein of the affected side was adequately and carefully dissected around the thrombus to the proximity of inferior vena cava (IVC) and was ligated with Hem-o-loks without cross-clamping the IVC. For level I and II VTT, the IVC was crossclamped cephalically and caudally around the tumor thrombus and all tributaries were sequentially blocked to ensure the safe retrieval of VTT. All operations were successfully completed without conversion to open operation. The mean operative time was 150 (115-230) min. Cross-clamping of the IVC happened in 3 cases, and the blocking time was 14, 19 and 20 min, respectively. The mean estimated blood loss during the operation was 400 (200-580) mL. The peritoneal drainage tube was removed 5 to 9 days after the operation, and all patients were postoperatively discharged at 6 to 11 days. Postoperative pathological analysis confirmed that the RCCs were comprised of 4 clear cell RCCs, 1 papillary cell RCC, and 1 medullary cell RCC; 2 cases were Fuhrman grade II, 3 cases grade III, and 1 case undefined grade. No recurrence or progression was observed during the follow-up of 4.2 (3-6) months. We concluded that RAL-NVT is highly challenging but safe and feasible for the treatment of RCC with VTT.

Entities:  

Keywords:  laparoscopy; renal cell carcinoma; robotics; thrombectomy; venous tumor thrombus

Mesh:

Year:  2018        PMID: 30341517     DOI: 10.1007/s11596-018-1950-x

Source DB:  PubMed          Journal:  Curr Med Sci        ISSN: 2523-899X


  16 in total

1.  Pure laparoscopic radical nephrectomy with level II vena caval thrombectomy.

Authors:  Frederico R Romero; Michael Muntener; Herman S Bagga; Fábio Augusto R Brito; Aaron Sulman; Thomas W Jarrett
Journal:  Urology       Date:  2006-11-07       Impact factor: 2.649

Review 2.  Robotic surgery and minimally invasive management of renal tumors with vena caval extension.

Authors:  Ronney Abaza
Journal:  Curr Opin Urol       Date:  2011-03       Impact factor: 2.309

3.  Prognostic indicators for renal cell carcinoma: a multivariate analysis of 643 patients using the revised 1997 TNM staging criteria.

Authors:  K H Tsui; O Shvarts; R B Smith; R A Figlin; J B deKernion; A Belldegrun
Journal:  J Urol       Date:  2000-04       Impact factor: 7.450

4.  Neoadjuvant targeted molecular therapies in patients undergoing nephrectomy and inferior vena cava thrombectomy: is it useful?

Authors:  Pierre Bigot; Tarek Fardoun; Jean Christophe Bernhard; Evanguelos Xylinas; Julien Berger; Morgan Rouprêt; Jean-Baptiste Beauval; Samuel Lagabrielle; Souhil Lebdai; Myriam Ammi; Hervé Baumert; Bernard Escudier; Nicolas Grenier; Jean-François Hétet; Jean-Alexandre Long; Philippe Paparel; Nathalie Rioux-Leclercq; Michel Soulié; Abdel-Rahmène Azzouzi; Karim Bensalah; Jean-Jacques Patard
Journal:  World J Urol       Date:  2013-04-27       Impact factor: 4.226

5.  Initial series of robotic radical nephrectomy with vena caval tumor thrombectomy.

Authors:  Ronney Abaza
Journal:  Eur Urol       Date:  2010-09-16       Impact factor: 20.096

6.  Robot-assisted radical nephrectomy with inferior vena cava tumor thrombectomy: technique and initial outcomes.

Authors:  Mark W Ball; Michael A Gorin; Gautam Jayram; Phillip M Pierorazio; Mohamad E Allaf
Journal:  Can J Urol       Date:  2015-02       Impact factor: 1.344

7.  Multi-Institutional Experience with Robotic Nephrectomy with Inferior Vena Cava Tumor Thrombectomy.

Authors:  Ronney Abaza; Ahmad Shabsigh; Erik Castle; Mohamad Allaf; Jim C Hu; Craig Rogers; Mani Menon; Monish Aron; Chandru P Sundaram; Daniel Eun
Journal:  J Urol       Date:  2015-11-19       Impact factor: 7.450

8.  Robotic Level III Inferior Vena Cava Tumor Thrombectomy: Initial Series.

Authors:  Inderbir S Gill; Charles Metcalfe; Andre Abreu; Vinay Duddalwar; Sameer Chopra; Mark Cunningham; Duraiyah Thangathurai; Osamu Ukimura; Raj Satkunasivam; Andrew Hung; Rocco Papalia; Monish Aron; Mihir Desai; Michele Gallucci
Journal:  J Urol       Date:  2015-04-06       Impact factor: 7.600

Review 9.  Robotic Surgery for Renal Cell Carcinoma with Vena Caval Tumor Thrombus.

Authors:  Ronney Abaza; Daniel D Eun; Michele Gallucci; Inderbir S Gill; Mani Menon; Alexandre Mottrie; Ahmad Shabsigh
Journal:  Eur Urol Focus       Date:  2017-01-20

10.  Robot-assisted Level II-III Inferior Vena Cava Tumor Thrombectomy: Step-by-Step Technique and 1-Year Outcomes.

Authors:  Sameer Chopra; Giuseppe Simone; Charles Metcalfe; Andre Luis de Castro Abreu; Jamal Nabhani; Mariaconsiglia Ferriero; Alfredo Maria Bove; Rene Sotelo; Monish Aron; Mihir M Desai; Michele Gallucci; Inderbir S Gill
Journal:  Eur Urol       Date:  2016-09-20       Impact factor: 20.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.